Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

3-4 March 2017

Madrid, Spain


The following companies are supporters of this Congress:


Lilly Oncology

Lilly Oncology is dedicated to advancing treatment and addressing the unmet needs of people living with cancer. Building on our work in cancer treatment, we are committed to creating a broad portfolio with research focused in three areas—tumor cell signaling, microenvironment, and immuno oncology—and exploring different combinations and sequencing of therapy so we can help advance treatment for more people. Our hope is to optimize cancer patient outcomes and find meaningful and practical ways to support patients, caregivers, and the care team throughout the cancer journey.



PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. We are an integrated company that seeks innovative products to provide healthcare professionals with new tools to treat cancer.

PharmaMar’s commitment to patients and to research has made it a world leader in the discovery of antitumor drugs of marine origin.


Supported by an educational grant from:


Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex by email at